The catalytic properties of nanoparticles (e.g., nano zero valent iron, nZVI) have been used to effectively treat a wide range of environmental contaminants. Emerging contaminants such as endocrine disrupting chemicals (EDCs) are susceptible to degradation by nanoparticles. Despite extensive investigations, questions remain on the transformation mechanism on the nZVI surface under different environmental conditions (redox and pH). Furthermore, in terms of the large-scale requirement for nanomaterials in field applications, the effect of polymer-stabilization used by commercial vendors on the above processes is unclear. To address these factors, we investigated the degradation of a model EDC, the steroidal estrogen 17α-ethinylestradiol (EE2), by commercially sourced nZVI at pH 3, 5 and 7 under different oxygen conditions. Following the use of radical scavengers, an assessment of the EE2 transformation products shows that under nitrogen purging direct reduction of EE2 by nZVI occurred at all pHs. The radicals transforming EE2 in the absence of purging and upon air purging were similar for a given pH, but the dominant radical varied with pH. Upon air purging, EE2 was transformed by the same radical species as the non-purged system at the same respective pH, but the degradation rate was lower with more oxygen - most likely due to faster nZVI oxidation upon aeration, coupled with radical scavenging. The dominant radicals were OH at pH 3 and O2- at pH 5, and while neither radical was involved at pH 7, no conclusive inferences could be made on the actual radical involved at pH 7. Similar transformation products were observed without purging and upon air purging.
(1) Background: We studied the association of both conventional (BMI, waist and hip circumference and waist-hip ratio) and novel (UK clothing sizes) obesity indices with pancreatic cancer risk in the UK women's cohort study (UKWCS). (2) Methods: The UKWCS recruited 35,792 women from England, Wales and Scotland from 1995 to 1998. Cancer diagnosis and death information were obtained from the National Health Service (NHS) Central Register. Cox's proportional hazards regression was used to evaluate the association between baseline obesity indicators and pancreatic cancer risk. (3) Results: This analysis included 35,364 participants with a median follow-up of 19.3 years. During the 654,566 person-years follow up, there were 136 incident pancreatic cancer cases. After adjustments for age, smoking, education and physical activity, each centimetre increase in hip circumference (HR: 1.03, 95% CI: 1.01-1.05, p = 0.009) and each size increase in skirt size (HR: 1.12, 95% CI: 1.02-1.23, p = 0.041) at baseline increased pancreatic cancer risk. Baseline BMI became a significant predictor of pancreatic cancer risk (HR: 1.04, 95% CI: 1.00-1.08, p = 0.050) when latent pancreatic cancer cases were removed. Only baseline hip circumference was associated with pancreatic cancer risk (HR: 1.03, 95% CI: 1.00-1.05, p = 0.017) when participants with diabetes at baseline were excluded to control for reverse causality. (4) Conclusion: Hip circumference and skirt size were significant predictors of pancreatic cancer risk in the primary analysis. Thus, hip circumference is useful to assess body shape relationships. Additionally, standard skirt sizes offer an economical and objective alternative to conventional obesity indices for evaluating pancreatic cancer risk in women.